Kalorama To Present IVD Market Findings at BIOMEDevice

In many ways, the IVD market of today does not resemble the market five years ago.  2018 appears to be the year where a number of trends that had been discussed began to gel.  With that in mind, Kalorama Information will be on hand for UBM’s BIOMedDevice Convention in San Jose, CA next month.   In […]

China’s IVD Market: Attractive Target for Surplus Growth

China’s IVD market reached $3,200 million in 2017, in line with growth estimates published by Kalorama and elsewhere, and the fast pace of market growth is expected to continue. Supporting growth will be a modernizing healthcare infrastructure and steady migration from manual to automated processes. This was the conclusion of Kalorama Information’s recent report, IVD in […]

Molecular Diagnostics Faces Competition for Future Point of Care Testing in Developing World

Multiplex Immunoassays Could Develop as a Cheaper Panel Testing Option for Tropical Diseases Kalorama Information reports cover the related global markets for point of care (POC) diagnostics and molecular POC diagnostics. Make sure to visit our Point of Care Testing page, Kalorama’s all-in-one resource covering the POC testing market.  The sensitivity and specificity of nucleic acid analytes provide molecular […]

Recent Autism Test Studies Add to Promising, Yet Inconclusive Research into Psychiatric Diagnostics

Kalorama Information covers in vitro diagnostics (IVD) markets for autism spectrum disorders (ASDs) and other psychiatric disorders in The World Molecular Diagnostics Market, 7thEd.  and Novel Autism Diagnostics. In two recent studies, in vitro diagnostic (IVD) assays have been investigated that incorporate biomarkers for environmental factors and dysfunctional cellular pathways associated with autism spectrum disorders (ASDs). The accuracy […]